This guideline summarizes the principles and approaches recommended by the FDA for process validation in the manufacture of drugs and biological products for humans and animals. It incorporates best practices that manufacturers can use to validate their production processes and aligns these with the product lifecycle concept and existing FDA and ICH guidelines.